Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1989-03-13
1990-10-16
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
549264, 549292, 549216, 549 60, 549 6, 544 57, 544 70, 544 6, 544149, 544374, 544230, 544232, 546 15, 546 22, 546204, 546256, 548517, 548407, 548413, 514460, 514824, 5142278, 5142315, 514255, 514326, 514278, 514409, 514422, 514444, 514459, 514330, A61K 31365, C07D30930
Patent
active
049635387
ABSTRACT:
Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) or (II): ##STR1## wherein position 5 of the polyhydronaphthyl ring is singly or doubly bonded to oxygen or incorporated into a C.sub.3-7 carbocyclic ring.
REFERENCES:
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4517373 (1985-05-01), Terahara et al.
patent: 4537859 (1985-08-01), Terahara et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4733003 (1986-03-01), Ide et al.
Duggan Mark E.
Hartman George D.
DiPrima Joseph F.
Merck & Co. , Inc.
Raymond Richard L.
Russell Mark W.
Winokur Melvin
LandOfFree
5-oxygenated HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-oxygenated HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-oxygenated HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849956